Price target
10.750.000.00%
The 2 analysts offering 1 year price forecasts for 609 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 2 analysts giving stock ratings to 609 in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
In the next quarter ABIONYX Pharma SA revenue is expected to reach 2.10 M EUR. Check out ABIONYX Pharma SA revenue and earnings and make informed decisions.
According to analysts, 609 price target is 10.75 EUR with a max estimate of 11.50 EUR and a min estimate of 10.00 EUR. Check if this forecast comes true in a year, meanwhile watch ABIONYX Pharma SA stock price chart and keep track of the current situation with 609 news and stock market news.